Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
Menno T. de Bruijn(Heidelberg University), Onno Kranenburg(Utrecht University)
Cited by 26
Related Papers
Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
|Acta Physiologica|2019|122
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
|Frontiers in Immunology|2023|104
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage
|Cancer Research|2022|84
A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research
|Cancer Treatment Reviews|2021|38
Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737
|Cellular Oncology|2011|18